NCT04551560
Stress and Congestive Heart Failure
Yale University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Congestive Heart Failure
- Drug/Device/Intervention
- Mental Stress
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Yale University
- Location
- New Haven, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 07, 2020
- End date
- Jun 30, 2025
- Enrollment
- 112 participants
Primary outcome
Pulmonary Artery Pressure
Summary
The purpose of this study is to investigate whether acute stress can precipitate congestive
 heart failure (CHF) exacerbation in patients with CHF.
ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04551560
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04551560 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 112 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.